Cellphire Therapeutics
Dr. Beveridge was previously Chief Medical Officer, McKesson Specialty Health, The US Oncology Network, Executive Vice President/Medical Director and Chairman, Public Policy and Bone Marrow Transplantation, at US Oncology, and Chief Medical Officer at Humana, Inc. He also served as Co-Director of Bone Marrow Transplant Program, INOVA Fairfax Hospital. Dr. Beveridge’s research has focused on oncology, stem cells and cord blood, and he is the author of more than 180 peer reviewed publications in these fields. He is currently Senior Healthcare Advisor at Avalere Health, and a member of the American Society of Hematology. Dr. Beveridge received a Doctor of Medicine from Cornell University and a Bachelor of Arts in cell biology from John Hopkins University.
This person is not in the org chart
This person is not in any offices
Cellphire Therapeutics
3 followers
Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products.